Kleo Pharmaceuticals is a company that provides Health care, Small molecule, Coronavirus disease 2019 (COVID-19) and more. Kleo Pharmaceuticals is headquartered in United States Connecticut. Kleo Pharmaceuticals was founded in 2015. and was founded by David A. Spiegel, Roy Prieb. Kleo Pharmaceuticals has a total of 65 patents
Related Topics
Health careSmall moleculeCoronavirus disease 2019 (COVID-19)Synthetic antibodyClinical researchAntibodyDrug discoveryExosomeBiomedicineBiotechnologyPharmaceuticsAptamerDrug designCancer researchToxicologyBiophysicsContract research organizationBiochemistryClinical trial
Kleo is developing two types of small molecules to treat cancer, infectious diseases, and a broad range of indications: Antibody Recruiting Molecules (ARMs)...